Come hear our CEO’s presentation to learn how to radically increase the productivity of your preclinical R&D !
As one of the event’s Spotlight Partners, INOVOTION will be among the speakers. Our founder and CEO, Jean Viallet, PhD, will open the session “Minimising the Translational Gap from Preclinical to Clinical Through Next Generation in Vivo Models”, Dec 6th at 12:10 pm. Don’t miss his speech describing INOVOTION’s Technology for Oncology Drug Discovery. It will focus on the Early In Vivo Identification of Low Value Molecules – a very hot topic right now in the pharmaceutical industry.
See you in London!
Come meet Jean Viallet, PhD, CEO jean.viallet@inovotion.com or Arnaud Peyronnier, Business Development Manager arnaud.peyronnier@inovotion.com
